# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001654954-18-002638
Filing Date
2018-03-15
Accepted
2018-03-15 17:29:31
Documents
69
Period of Report
2017-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | v031418_10K.htm | 10-K | 1874159
2 | EXHIBIT 21.1 | tgtx_ex211.htm | EX-21.1 | 2670
3 | EXHIBIT 23.1 | tgtx_ex231.htm | EX-23.1 | 4688
4 | EXHIBIT 31.1 | tgtx_ex311.htm | EX-31.1 | 18355
5 | EXHIBIT 31.2 | tgtx_ex312.htm | EX-31.2 | 18533
6 | EXHIBIT 32.1 | tgtx_ex321.htm | EX-32.1 | 6401
7 | EXHIBIT 32.2 | tgtx_ex322.htm | EX-32.2 | 6350
8 | EXHIBIT 10.20 | tgtx_ex1020.htm | EX-10.20 | 352909
9 | IMAGE | image01.jpg | GRAPHIC | 38385
| Complete submission text file | 0001654954-18-002638.txt |  | 6078875

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | XBRL INSTANCE DOCUMENT | tgtx-20171231.xml | EX-101.INS | 1051797
11 | XBRL TAXONOMY EXTENSION SCHEMA | tgtx-20171231.xsd | EX-101.SCH | 50720
12 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | tgtx-20171231_cal.xml | EX-101.CAL | 59711
13 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | tgtx-20171231_def.xml | EX-101.DEF | 145513
14 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | tgtx-20171231_lab.xml | EX-101.LAB | 326960
15 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | tgtx-20171231_pre.xml | EX-101.PRE | 242413

Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

EIN.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32639 | Film No.: 18693479
SIC: 2834 Pharmaceutical Preparations